Pulmonary response to methylcyclopentadienyl manganese tricarbonyl treatment in rats: injury and repair evaluation.
Methylcyclopentadienyl manganese tricarbonyl (MMT), an organometallic compound, used as an antiknock additive in fuels, may produce alveolar inflammation and bronchiolar cell injury. The aim of the experimental study on female rats was to determine by morphological examination and sensitive biomarkers, the course of the injury and repair process following a single i.p. injection of 5 mg/kg MMT. The animals were sacrificed 12, 24, 48 hours or 7 days post-exposure (PE). The first biochemical changes 12 h PE showed an increase in GSH-S-transferase (GST) activity in the lung parallel to the earliest observed morphological changes -vacuolation and swollen cytoplasm in type I pneumocytes. Alterations in type I pneumocytes were most prevalent in rat lung 24 h PE. Clara cells with dilated smooth endoplasmic reticulum membranes and cytoplasmic vacuolation could be observed. Compared to the values found for controls, Clara cell protein (CC16) in the bronchoalveolar lavage fluid (BALF) at 24 and 48 h PE decreased by 58% and 55%, respectively. At the same time (at 24 and 48 h), the total protein concentration in BALF increased 5 and 7 times, respectively. A significant rise in hyaluronic acid (HA) level was observed 24 and 48 h PE. Divided type II pneumocyte cells and Clara cells in their mitotic phase were observed in immunocytochemistry (detecting BrdU binding into DNA) 48 h PE. Seven days after MMT administration, fibroblasts, macrophages, collagen and elastin fibres could be seen in the alveolar walls as well as neutrophils, lymphocytes, and alveoli macrophages in the alveolar lumen. We conclude that injury and repair of bronchial epithelium cells, especially of Clara cells and type II pneumocyte cells, play an important part in MMT toxicity, probably depending on the antioxidant status of these cells. The sensitive biomarkers of CC16 and hyaluronic acid in BALF and serum reflect lung injury and indicate the time course of pulmonary damage and repair processes.
Halatek
T
T
Department of Toxicology and Carcinogenesis, Nofer Institute of Occupational Medicine, Lodz, Poland. halatek@imp.lodz.pl
Opalska
B
B
Rydzynski
K
K
Bernard
A
A
D000818:Animals; D001980:Bronchi / Q000473:pathology; D001992:Bronchoalveolar Lavage Fluid; D004721:Endoplasmic Reticulum / Q000378:metabolism; D004848:Epithelium / Q000473:pathology; D005260:Female; D005982:Glutathione Transferase / Q000378:metabolism; D006820:Hyaluronic Acid / Q000494:pharmacology; D007150:Immunohistochemistry; D008168:Lung / Q000187:drug effects / Q000473:pathology / Q000648:ultrastructure; D055370:Lung Injury; D009942:Organometallic Compounds / Q000633:toxicity*; D011650:Pulmonary Alveoli; D051381:Rats; D017208:Rats, Wistar; D014598:Uteroglobin / Q000378:metabolism
D009942:Organometallic Compounds; C556391:Scgb1a1 protein, rat; C009907:2-methylcyclopentadienyl manganese tricarbonyl; D006820:Hyaluronic Acid; D014598:Uteroglobin; D005982:Glutathione Transferase